These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18061205)

  • 1. The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.
    Garcia-Saez I; Docquier JD; Rossolini GM; Dideberg O
    J Mol Biol; 2008 Jan; 375(3):604-11. PubMed ID: 18061205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.
    Christopeit T; Yang KW; Yang SK; Leiros HK
    Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):813-819. PubMed ID: 27834790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of VIM-1 complexes explain active site heterogeneity in VIM-class metallo-β-lactamases.
    Salimraj R; Hinchliffe P; Kosmopoulou M; Tyrrell JM; Brem J; van Berkel SS; Verma A; Owens RJ; McDonough MA; Walsh TR; Schofield CJ; Spencer J
    FEBS J; 2019 Jan; 286(1):169-183. PubMed ID: 30430727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
    Leiros HK; Skagseth S; Edvardsen KS; Lorentzen MS; Bjerga GE; Leiros I; Samuelsen Ø
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4826-36. PubMed ID: 24913158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and computational investigations of VIM-7: insights into the substrate specificity of vim metallo-β-lactamases.
    Borra PS; Leiros HK; Ahmad R; Spencer J; Leiros I; Walsh TR; Sundsfjord A; Samuelsen O
    J Mol Biol; 2011 Aug; 411(1):174-89. PubMed ID: 21645522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
    Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
    Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three-dimensional structure of VIM-31--a metallo-β-lactamase from Enterobacter cloacae in its native and oxidized form.
    Kupper MB; Herzog K; Bennink S; Schlömer P; Bogaerts P; Glupczynski Y; Fischer R; Bebrone C; Hoffmann KM
    FEBS J; 2015 Jun; 282(12):2352-60. PubMed ID: 25825035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.
    Lauretti L; Riccio ML; Mazzariol A; Cornaglia G; Amicosante G; Fontana R; Rossolini GM
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1584-90. PubMed ID: 10390207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.
    Leiros HK; Borra PS; Brandsdal BO; Edvardsen KS; Spencer J; Walsh TR; Samuelsen O
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4341-53. PubMed ID: 22664968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biochemical characterization of VIM-26 shows that Leu224 has implications for the substrate specificity of VIM metallo-β-lactamases.
    Leiros HK; Edvardsen KS; Bjerga GE; Samuelsen Ø
    FEBS J; 2015 Mar; 282(6):1031-42. PubMed ID: 25601024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.
    Mojica MF; Mahler SG; Bethel CR; Taracila MA; Kosmopoulou M; Papp-Wallace KM; Llarrull LI; Wilson BM; Marshall SH; Wallace CJ; Villegas MV; Harris ME; Vila AJ; Spencer J; Bonomo RA
    Biochemistry; 2015 May; 54(20):3183-96. PubMed ID: 25915520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
    Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
    Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
    Juan C; Beceiro A; Gutiérrez O; Albertí S; Garau M; Pérez JL; Bou G; Oliver A
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3589-96. PubMed ID: 18644957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor.
    Yamaguchi Y; Jin W; Matsunaga K; Ikemizu S; Yamagata Y; Wachino J; Shibata N; Arakawa Y; Kurosaki H
    J Med Chem; 2007 Dec; 50(26):6647-53. PubMed ID: 18052313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.
    Morán-Barrio J; Lisa MN; Larrieux N; Drusin SI; Viale AM; Moreno DM; Buschiazzo A; Vila AJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6013-22. PubMed ID: 27458232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
    Shakibaie MR; Azizi O; Shahcheraghi F
    Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-β-Lactamase from Pseudomonas stutzeri.
    Booth MP; Kosmopoulou M; Poirel L; Nordmann P; Spencer J
    PLoS One; 2015; 10(10):e0140059. PubMed ID: 26451836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
    Borgianni L; Vandenameele J; Matagne A; Bini L; Bonomo RA; Frère JM; Rossolini GM; Docquier JD
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3197-204. PubMed ID: 20498317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.